Kymera Therapeutics, Inc. · NASDAQ:KYMR

Goodman Noah sold 5,000 Kymera Therapeutics, Inc. shares (Form 4)

Traded Jun 25, 2026 · Filed Jun 25, 2026

On Jun 25, 2026, Goodman Noah (Chief Business Officer) sold 5,000 Kymera Therapeutics, Inc. shares at an average US$114.00 for US$570K under a trading plan, leaving 50,195 shares. Filed Jun 25, 2026 (Form 4).

Sold: 5,000 shares
Price: US$114.00 average (US$109.00 to US$119.00)
Value: US$570K
Holding after: 50,195 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Business Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 25, 2026	Common Stock	Option exercise	5,000	US$21.05	55,195	Direct
Jun 25, 2026	Common Stock	Sale	2,500	US$109.00	52,695	Direct
Jun 25, 2026	Common Stock	Sale	2,500	US$119.00	50,195	Direct

Source

View original at SEC

Related